R3 Delta Ceramic Acetabular System PAS U.S.

NCT03056534 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2025-04-13

Study results available
· View outcomes & findings →

Summary

R3 Delta Post-Approval Study U.S.

Conditions

  • Degenerative Joint Disease

Interventions

DEVICE

R3 Biolox Delta Ceramic Acetabular System

All study related procedures with the R3 delta Ceramic Acetabular System must be performed according to the recommended surgical technique described in the labeling and in the instructions for use (IFU).

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-07
Primary Completion
2023-05-31
Completion
2023-05-31
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03056534 on ClinicalTrials.gov